Barclays PLC lifted its position in ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 338.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,437 shares of the company's stock after buying an additional 33,529 shares during the quarter. Barclays PLC owned approximately 0.16% of ZimVie worth $690,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of ZIMV. Rhumbline Advisers lifted its stake in ZimVie by 6.6% in the 2nd quarter. Rhumbline Advisers now owns 44,699 shares of the company's stock worth $816,000 after purchasing an additional 2,760 shares in the last quarter. American Century Companies Inc. raised its position in shares of ZimVie by 212.8% in the second quarter. American Century Companies Inc. now owns 412,434 shares of the company's stock worth $7,527,000 after buying an additional 280,565 shares in the last quarter. WINTON GROUP Ltd purchased a new stake in shares of ZimVie in the second quarter worth $209,000. Massachusetts Financial Services Co. MA boosted its stake in ZimVie by 3.5% during the second quarter. Massachusetts Financial Services Co. MA now owns 102,431 shares of the company's stock valued at $1,869,000 after buying an additional 3,441 shares during the period. Finally, Dimensional Fund Advisors LP grew its position in ZimVie by 3.7% during the second quarter. Dimensional Fund Advisors LP now owns 1,035,069 shares of the company's stock worth $18,889,000 after buying an additional 36,846 shares in the last quarter. 95.63% of the stock is currently owned by institutional investors.
ZimVie Price Performance
NASDAQ ZIMV traded up $0.24 during trading on Friday, reaching $14.29. The company's stock had a trading volume of 113,247 shares, compared to its average volume of 93,795. The stock has a market capitalization of $394.40 million, a PE ratio of -1.09 and a beta of 2.11. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.94 and a quick ratio of 1.38. The firm has a fifty day moving average of $13.96 and a 200 day moving average of $15.95. ZimVie Inc. has a one year low of $13.01 and a one year high of $22.40.
ZimVie Profile
(
Free Report)
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Featured Articles
Before you consider ZimVie, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZimVie wasn't on the list.
While ZimVie currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
